Diagnostic validity of the immunoenzyme analysis in patients with tuberculosis and inspecific pulmonary diseases

Autor:	S. B. Sadykov, S. E. Kukarkin, S. A. Nureyev, O. V. Shakurova, G. A. Zinurova, A. Z. Tutik, V. V. Lemeshko, L. P. Erokhova
Rok vydání:	1998
Předmět:	medicine.medical_specialty Tuberculosis business.industry Internal medicine Diagnostic validity Medicine In patient General Medicine business medicine.disease
Zdroj:	Kazan medical journal. 79:419-421
ISSN:	2587-9359 0368-4814
DOI:	10.17816/kazmj64899
Popis:	Validity of the immunoenzyme analysis is studied in 273 patients, being ill with tuberculosis for the first time (the 1st group), 75 patients with acute condition and relapse of tuberculosis (the 2d group), 144 patients with inspecific pulmonary diseases (the 3d group) and 40 healthy persons (the control group). The specific antibodies are revealed in 50,5%, 66,7%, 28,5% and 7,5% of the cases in the groups observed, respectively. The largest number of antibodies in patients of the 1st and 2d groups is observed in fibrocavernous tuberculosis 75% and 91,5%, respectively and in the patients of the 2-rd group in disseminated tuberculosis 75%. The incidence of their revealing in patients of the 2-rd group with bacteriodischarge especially with massive is higher than in patients of the 1st group with similar tuberculosis parameters (67,6% and 78%, 51,5% and 56,6%, respectively). Similar tendency is found in destructive changes in lungs. The incidence of revealing antibodies in the immunoenzyme analysis is 79,3% in patients of the 2-rd group with decay cavities and 56,2% in patients of the 1st group.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::19a9f7fde5257a65758f953b4a9c0718 https://doi.org/10.17816/kazmj64899 Zobrazit plný text záznamu